Avantor, Inc. (AVTR) stock analysis
Close on Nov 11, 2026Market cap $10.66BP/E 31.5Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Mixed10 of 30 checks passed
Avantor passes 10 of the 30 checks behind our score; 9 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 5/6
- Growth
- 0/6
- Past performance
- 3/6
- Financial health
- 2/6
- Dividend
- 0/6
What stands out
Trading below fair value
The share price of $15.73 is below our fair value estimate of $19.15.
P/E below its 5-year median
Avantor's P/E of 31.5 is below its own 5-year median of 33.5.
P/E below the industry
Avantor's P/E of 31.5 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 36.5.
EV/EBITDA below its 5-year median
Avantor's EV/EBITDA of 15.3 is below its 5-year median of 17.8.
What to watch
Margin of safety under 20%
The price is 17.9% below fair value, less than the 20% cushion we look for.
Return on equity under 15%
Return on equity was 5.9% over the last twelve months and averaged 8.3% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 5.3%, below the 10% that usually covers the cost of capital.
High debt
Debt is 63.1% of shareholders' equity, above the 40% we consider low.
Valuation5/6
P/E below its 5-year median
Avantor's P/E of 31.5 is below its own 5-year median of 33.5.
P/E below the industry
Avantor's P/E of 31.5 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 36.5.
EV/EBITDA below its 5-year median
Avantor's EV/EBITDA of 15.3 is below its 5-year median of 17.8.
P/B below the industry
Avantor's price-to-book of 1.83 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.17.
Trading below fair value
The share price of $15.73 is below our fair value estimate of $19.15.
Margin of safety under 20%
The price is 17.9% below fair value, less than the 20% cushion we look for.
Growth0/6
Revenue growing under 10% a year
Revenue grew -4.5% a year over the last three fiscal years, short of the 10% we look for.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing slower than the industry
Revenue grew 0.9% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.4%.
Guidance issued
The latest outlook (Fiscal 2026 Organic revenue growth, Oct 28, 2026) was issued for the first time, so it neither adds nor takes away points.
Gross margin slipping
Gross margin was 31.6% over the last twelve months, against 33.1% a year earlier.
Past performance3/6
Return on equity under 15%
Return on equity was 5.9% over the last twelve months and averaged 8.3% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 5.3%, below the 10% that usually covers the cost of capital.
Return on equity above the industry
Avantor's return on equity of 5.9% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 1.1%.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin above its 5-year average
Net margin was 5.1% over the last twelve months, against a 5-year average of 4.8%.
Net margin above the industry
Avantor's net margin of 5.1% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of -1.3%.
Financial health2/6
High debt
Debt is 63.1% of shareholders' equity, above the 40% we consider low.
Debt falling against equity
Debt to equity fell from 183% five years ago to 63.1%.
Debt not well covered by cash flow
Operating cash flow over the last twelve months equals 15.9% of total debt; we look for at least 20%.
Interest not well covered
Operating income covers interest expense 3.0 times; we look for at least 5.
Short-term assets cover short-term debts
Current assets are 1.89 times current liabilities.
Bankruptcy risk in the grey zone
The Altman Z-score is 2.17; above 3 is the safe zone and below 1.8 the distress zone.
Dividend0/6
No dividend
Avantor has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itOur estimate per share
$19.15
The share price is 18% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 35.0× | 33.5× | 36.5× | $17.51 | 40% |
| EV/EBITDA | 20.7× | 17.8× | 23.7× | $22.98 | 35% |
| P/B | 3.0× | 2.8× | 3.2× | $25.72 | 10% |
| Earnings power | 9.2% cost of equity | – | – | $10.21 | 15% |
| Fair value | $19.15 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 33.5
- Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median 36.5
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $157.80M
- Value traded per 1% price move
- $76.45M
Downside
High risk
- Typical loss in a bad month
- 25.4%
- Volatility (annualized)
- 43%
- Sharpe ratio, 1 year
- 0.75
- Beta to the S&P 500 (5Y)
- 0.87
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2016 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -3.4% | -4.5% | +0.5% | – | |
| Gross profit | -6.1% | -6.3% | +0.6% | – | |
| Free cash flow | -28.5% | -11.3% | -10.6% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | 4.5% | -9.2% | |
| Return on assets | – | 1.2% | -4.4% | |
| Current ratio | – | 1.80 | 1.78 | |
| Debt to equity | – | 1.83 | 0.71 | |
| Net debt to EBITDA | – | 4.18× | 21.83× | |
| Interest coverage | – | 2.3× | -1.4× | |
| Inventory turnover | – | 5.9× | 5.7× | |
| Capex to revenue | – | 1.0% | 2.0% | |
| Diluted shares | – | 583M | 681M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Avantor generated $4.13B from operations and spent $743.60M on capital expenditure, dividends and share buybacks. 90% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -8.1% | 0.55× | 2.08× | -9.2% |
| FY2024 | 10.5% | 0.54× | 2.24× | 12.7% |
| FY2023 | 4.6% | 0.53× | 2.62× | 6.4% |
| FY2022 | 9.1% | 0.55× | 3.02× | 15.2% |
| FY2021 | 7.8% | 0.62× | 3.46× | 16.7% |
| FY2020 | 1.8% | 0.65× | 3.83× | 4.5% |
| FY2019 | 0.6% | 0.61× | -33.39× | -12.8% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero-$530.20M
- Cash generatingOperating cash flow above zero$623.80M
- Return on assets improvedROA up on the prior year5.5% → -4.4%
- Earnings backed by cashOperating cash flow above net income$623.80M vs -$530.20M
- Less leverageLong-term debt to assets fell26.7% → 33.2%
- Better liquidityCurrent ratio rose1.07 → 1.78
- No dilutionShare count did not rise682M → 681M
- Gross margin improvedGross margin up on the prior year33.60% → 32.65%
- More efficientAsset turnover rose0.52 → 0.54
See a number that looks wrong?